Oncology

Abiraterone - Abstet tablets

Abiraterone - Abstet tablets

Abstet tablets contains Abiraterone Acetate 250mg.

Abstet (generic Abiraterone) tablets is available in 250mg strength. Abstet (generic Abiraterone) tablets is a product of by Biocon.

Abstet (generic Abiraterone) tablets is available in a bottle pack of 120 tablets.

Abstet (generic Abiraterone) tablets is available with Avalon Pharma Pvt Ltd.

Abiraterone - XBIRA tablets

Abiraterone - XBIRA tablets

XBIRA (generic Abiraterone) tablets manufactured by Cipla.

XBIRA (generic Abiraterone) tablets contains Abiraterone Acetate 250mg.

XBIRA tablets is available in 250mg strength.

XBIRA (generic Abiraterone) tablets is available in a bottle pack of 120 tablets. XBIRA tablets is available with Avalon Pharma Pvt Ltd.

Abiraterone - Zelgor tablets

Abiraterone - Zelgor tablets

Zelgor tablets contains Abiraterone Acetate 250mg.

Zelgor (generic Abiraterone) tablets is available in 250mg strength.

Zelgor (generic Abiraterone) tablets is a product of by Sun Pharma.

Zelgor (generic Abiraterone) tablets is available in a bottle pack of 120 tablets

Zelgor (generic Abiraterone) tablets is available with Avalon Pharma Pvt Ltd.

Bevacizumab - BEVAZZA

Bevacizumab - BEVAZZA

Bevazza (Bevacizumab) is available in a single dose vial with two strengths, 100 mg and 400 mg.

Bevazza (Bevacizumab) biosimilar of Avastin is manufactured by Lupin

Bevacizumab - CIZUMAB

Bevacizumab - CIZUMAB

Cizumab (Bevacizumab) is available in a single dose vial with two strengths, 100 mg and 400 mg.

Cizumab (Bevacizumab) biosimilar of Avastin is manufactured by Hetero Pharma

Bicalutamide - CALUTIDE

Bicalutamide - CALUTIDE

Calutide (Bicalutamide 50mg) tablets are indicated in the treatment of advanced prostate cancer in combination with LHRH analogue therapy or surgical castration.

Calutide (Bicalutamide 50mg) is indicated either alone or as adjuvant to radical prostatectomy or radiotherapy in patients with locally advanced prostate cancer at high risk for disease progression.

Calutide (Bicalutamide 50mg) is also indicated for the management of patients with locally advanced, non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

Bleomycin Inj

Bleomycin Inj

Bleomycin should be considered a palliative treatment. It has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents:

Squamous Cell Carcinoma
Head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. The response to Bleomycin is poorer in patients with previously irradiated head and neck cancer.

Lymphomas
Hodgkin`s Disease, non-Hodgkin`s lymphoma.

Testicular Carcinoma
Embryonal cell, choriocarcinoma, and teratocarcinoma.

Bleomycin has also been shown to be useful in the management of:
Malignant Pleural Effusion - Bleomycin is effective as a sclerosing agent for the treatment of malignant pleural effusion and prevention of recurrent pleural effusions.

Capecitabine - Capegard

Capecitabine - Capegard

CAPEGARD 500 Tablets are indicated for the first-line treatment of patients with metastatic colorectal carcinoma when treatment with fluoropyrimidine therapy alone is preferred. Combination chemotherapy has shown a survival benefit compared to 5-FU/LV alone. A survival benefit over 5-FU/LV has not been demonstrated with CAPEGARD 500 Tablets monotherapy. Use of CAPEGARD 500 Tablets instead of 5-FU/LV in combinations has not been adequately studied to assure safety or preservation of the survival advantage.

Chlorambucil - Clokeran

Chlorambucil - Clokeran

Clokeran (generic Chlorambucil) is manufactured by Natco Pharma

Clokeran (generic Chlorambucil) is available in 2mg & 5mg strengths.

Clokeran (generic Chlorambucil) comes in a bottle pack of 30 tablets

  • 1
  • 2
  • 3
  • 4
  • 5